Public facts
McKinsey's April AI survey reports implementation at half of the 150 responding organizations. Integration and internal capability are prominent scaling barriers. These are survey responses collected in 2025, not a census or a September 2026 adoption estimate.
The July future-of-work article argues that productivity requires changes to workflows and roles, rather than technology layered onto existing processes.
The April revenue-cycle survey describes pressure across collections, reimbursement, and administrative processes. Its findings reflect 215 US leaders surveyed in September 2025.
Rock Health's July market analysis reports concentrated digital-health funding and argues for domain expertise and measurable outcomes as differentiators. Its discussion also describes closer connections between digital care and pharmaceutical distribution. Funding is a market signal, not proof of patient benefit.
CMS proposed extending electronic prior authorization requirements to drugs in April 2026. This is distinct from its 2024 final rule for non-drug items and services; the proposal must not be represented as a current final drug requirement.
ONC describes TEFCA as a national framework for authorized information sharing among providers, patients, public health organizations, and payers. Exchange infrastructure does not, by itself, establish local workflow ownership.
FDA's August 18 discussion paper requests feedback on evaluation and monitoring of generative AI-enabled medical devices. It is not a final regulatory standard or a blanket rule for every administrative AI tool.
A July npj Digital Medicine letter proposes that meaningful oversight needs informed judgment, adequate attention, decision rights, and the ability to intervene. A May Nature Health perspective proposes continuity across repeated health interactions. These are frameworks, not trials proving patient outcomes; this brief uses their publicly available abstracts.